D-0834-2026 Class II Ongoing
FDA drug recall D-0834-2026 was initiated by Teva Pharmaceuticals USA, Inc on August 24, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing. Affected quantity: 175,392 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- September 9, 2026
- Initiation Date
- August 24, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 175,392 bottles
Product Description
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
Reason for Recall
Presence of Foreign Tablets/Capsules
Distribution Pattern
U.S. Nationwide
Code Information
Lot: 1394026, Exp. 02/2028.